Mandate

Vinge advises Qben Infra in connection with issuance of senior, unsecured bonds and early redemption

January 16, 2025

Vinge has advised Qben Infra AB in connection with its issuance of senior, unsecured bonds in an amount of SEK 500,000,000 (within a framework of SEK 600,000,000) and the parallel early redemption by its subsidiary ININ Group AS in respect of its previously issued senior secured bonds due 2027.

The new bonds have a tenor of three years and were issued with a coupon of STIBOR 3M + 800 basis points. The net proceeds will be used to refinance ININ Group’s previously issued bonds, the refinancing of certain bank debt within the Qben group and for general corporate purposes. The bonds are intended to be listed on Nasdaq Transfer Market and the corporate bond list of Nasdaq Stockholm.

DNB Bank ASA, filial Sverige, has acted as Sole Bookrunner.

Vinge's team consisted of Albert Wållgren, Lionardo Ojeda, Felix Möller, Calle Tengwall Pagels and August Ahlin.

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025